FindTrial
Sign In

Predictors of clinically significant bleeding in patients with Dengue admitted to intensive care unit- Retrospective study

Predictors of clinically significant bleeding in patients with Dengue admitted to Intensive care unit. - A retrospective study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/10/046155
Enrollment
120
Registered
2022-10-04
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A91- Dengue hemorrhagic fever

Interventions

None listed

Sponsors

DR PRIYA L
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Laboratory confirmed dengue patients Primary Dengue: Positive NS1 antigen-based ELISA test or Immunoglobulin M (IgM) rapid test for dengue virus. Secondary Dengue: IgG/IgM ratio � 1.1 (ELISA) IgG cut off >3 Platelet count

Exclusion criteria

Exclusion criteria: 1.Co-infections with other pathogens 2.Patients with other causes of thrombocytopenia ITP Chronic liver disease Haematological malignancies

Design outcomes

Primary

MeasureTime frame
To evaluate the Grades of Bleeding associated with thrombocytopenia. Severity of disease- Dengue Hemorrhagic Fever or Dengue Shock Syndrome. Duration of thrombocytopenia- Time to spontaneous recovery more than 50000 cells per cubic mm. Length of ICU stay Transfusion requirement Mortality Timepoint: 30 days—

Secondary

MeasureTime frame
Duration of thrombocytopenia Length of ICU stay Transfusion requirements mortalityTimepoint: 30 days—

Countries

India

Contacts

Public ContactPRIYA L

Sri Ramachandra institute of Higher education and research

renuramanujam@gmail.com8056126336

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026